- Home
- LOAN vs VTVT Comparison
LOAN vs VTVT Comparison
Compare LOAN & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOAN
- VTVT
- Stock Information
- Founded
- LOAN 1989
- VTVT 2015
- Country
- LOAN United States
- VTVT United States
- Employees
- LOAN N/A
- VTVT N/A
- Industry
- LOAN Real Estate Investment Trusts
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- LOAN Real Estate
- VTVT Health Care
- Exchange
- LOAN Nasdaq
- VTVT Nasdaq
- Market Cap
- LOAN 58.1M
- VTVT 56.7M
- IPO Year
- LOAN 1999
- VTVT 2015
- Fundamental
- Price
- LOAN $5.20
- VTVT $15.55
- Analyst Decision
- LOAN
- VTVT Strong Buy
- Analyst Count
- LOAN 0
- VTVT 2
- Target Price
- LOAN N/A
- VTVT $35.50
- AVG Volume (30 Days)
- LOAN 13.6K
- VTVT 3.2K
- Earning Date
- LOAN 07-21-2025
- VTVT 08-07-2025
- Dividend Yield
- LOAN 8.79%
- VTVT N/A
- EPS Growth
- LOAN N/A
- VTVT N/A
- EPS
- LOAN 0.48
- VTVT N/A
- Revenue
- LOAN $7,291,468.00
- VTVT $17,000.00
- Revenue This Year
- LOAN N/A
- VTVT N/A
- Revenue Next Year
- LOAN $4.41
- VTVT N/A
- P/E Ratio
- LOAN $10.90
- VTVT N/A
- Revenue Growth
- LOAN N/A
- VTVT N/A
- 52 Week Low
- LOAN $4.74
- VTVT $12.12
- 52 Week High
- LOAN $6.05
- VTVT $26.99
- Technical
- Relative Strength Index (RSI)
- LOAN 50.76
- VTVT 37.38
- Support Level
- LOAN $5.13
- VTVT $15.17
- Resistance Level
- LOAN $5.20
- VTVT $16.61
- Average True Range (ATR)
- LOAN 0.10
- VTVT 0.35
- MACD
- LOAN 0.01
- VTVT 0.00
- Stochastic Oscillator
- LOAN 47.93
- VTVT 24.58
About LOAN Manhattan Bridge Capital Inc
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.